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Background
Millions of patients with allergy to tree pollen are sensi-
tized to the major allergen of birch (Betula verrucosa)
pollen, Bet v 1. Bet v 1-specific IgE cross-reacts with Bet
v 1-homologous proteins from plant foods. Only little
information on functional IgE epitopes of Bet v 1 and
Bet v 1-like allergens in foods is available. We sought to
generate a synthetic protein tool to identify and analyze
functional immunoglobulin binding sites on Bet v 1 and
Bet v 1-like allergens.
Methods
A synthetic protein (synNCS) was engineered based on the
primary structures of both native Norcoclaurine synthase,
a non-allergenic protein of the Bet v 1 superfamily, and a
natural hypoallergenic Bet v 1 variant, respectively.
Recombinant synNCS was purified from Escherichia coli.
Site-directed mutagenesis was applied to generate synNCS
variants carrying potential IgE epitopes of Bet v 1. synNCS
and variants thereof were physicochemically characterized
using circular dichroism spectroscopy and dynamic light
scattering. To evaluate IgE interaction with synNCS, sera
of birch pollen allergic patients were tested for IgE binding
to purified synNCS in Western blot, ELISA, and cellular
mediator release assays.
Results
Recombinant synNCS variants were expressed in E. coli.
The theoretical secondary structure topology is similar to
Bet v 1. Very low IgE binding to synNCS could be
detected in Western blot analyses. However functional in
vitro IgE interaction with synNCS variants was dependent
of the number of potential Bet v 1 IgE epitope residues
inserted into the model protein. The synNCS variants
induced IgE-mediated mediator release in humanized rat
basophil leukemia cells sensitized with sera of birch pollen
allergic subjects.
Conclusion
synNCS, a non-allergenic Bet v 1-like scaffold model
protein, could be rendered capable of biologically func-
tional IgE-antibody interaction by insertion of potential
Bet v 1 epitope structures into the otherwise IgE-inert
synNCS using sera of birch pollen allergic patients.
Thus synNCS might be a useful molecular tool to speci-
fically analyze immunoglobulin epitopes of Bet v 1 and
Bet v 1-like allergens. The knowledge of determinants of
clinically relevant antibody-allergen interactions enables
new strategies in the diagnosis, prognosis, and therapy
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